DXCM - Dexcom Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Specialty Instruments - Surgical & Medical Instruments & Apparatus - DXCM (1093557)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S83+0+1-3-12

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-09-20
DXCMSayer Kevin RPres, CEOS - Sale$69.34-6,000298,826-2%-$416,044
2017-09-11
DXCMBalo Andrew KEVP, Reg. Strategy, ClinicalS - Sale$72.27-3,24489,282-4%-$234,441
2017-08-23
DXCMPacelli Steven RobertEVP, Strategy, Corp. Dev.S - Sale$75.26-3,987108,087-4%-$300,045
2017-08-23
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$75.26-1,63596,180-2%-$123,053
2017-08-11
DXCMSayer Kevin RPres, CEOS - Sale$69.77-6,000320,680-2%-$418,637
2017-08-10
DXCMBalo Andrew KEVP, Reg. Strategy, ClinicalS - Sale$71.18-3,24499,989-3%-$230,921
2017-07-24
DXCMPacelli Steven RobertEVP, Strategy, Corp. Dev.S - Sale$69.47-1,450112,074-1%-$100,725
2017-07-12
DXCMSayer Kevin RPres, CEOS - Sale$71.86-6,000326,680-2%-$431,174
2017-07-10
DXCMBalo Andrew KEVP, Reg. Strategy, ClinicalS - Sale$71.55-3,200103,233-3%-$228,972
2017-06-23
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$78.22-3,18797,815-3%-$249,273
2017-06-23
DXCMPacelli Steven RobertEVP, Strategy, Corp. Dev.S - Sale$78.19-1,450113,524-1%-$113,378
2017-06-12
DXCMBalo Andrew KEVP, Clinical, RegulatoryS - Sale$69.06-3,200106,433-3%-$220,989
2017-06-12
DXCMSayer Kevin RPres, CEOS - Sale$69.07-6,000332,680-2%-$414,411
2017-05-23
DXCMPacelli Steven RobertEVP, Strategy, Corp. Dev.S - Sale$68.24-1,450114,974-1%-$98,949
2017-05-23
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$68.29-3,182101,002-3%-$217,290
D
2017-05-17
DXCMSayer Kevin RPres, CEOS - Sale+OE$68.39-8,649338,680-2%-$591,525
2017-05-10
DXCMBalo Andrew KEVP, Clinical, RegulatoryS - Sale$71.93-3,200109,633-3%-$230,176
2017-04-24
DXCMPacelli Steven RobertEVP, Strategy, Corp. Dev.S - Sale$75.89-1,450117,424-1%-$110,041+3+8
2017-04-24
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$75.78-3,182104,184-3%-$241,131+3+8
2017-04-20
DXCMGregg Terrance HExec COBS - Sale$74.10-15,000506,902-3%-$1,111,5000+4
D
2017-04-17
DXCMSayer Kevin RPres, CEOS - Sale+OE$75.63-10,000343,680-3%-$756,317+2+1
2017-04-10
DXCMBalo Andrew KEVP, Clinical, RegulatoryS - Sale$78.19-3,200112,833-3%-$250,208-1-3-10
2017-03-23
DXCMPacelli Steven RobertEVP, Strategy, Corp. Dev.S - Sale$76.25-3,987118,874-3%-$304,006+1+3-10
2017-03-23
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$76.38-3,182107,366-3%-$243,029+1+3-10
2017-03-22
DXCMRoper JessSVP, CFOS - Sale$75.97-2,00054,949-4%-$151,937+1+3-10
D
2017-03-17
DXCMSayer Kevin RPres, CEOS - Sale+OE$77.82-10,000343,680-3%-$778,158+1+9-3
2017-03-14
DXCMKahn BarbaraDirS - Sale$77.36-3,00026,095-10%-$232,080+2-1-2
DM
2017-03-09
DXCMLeach Jacob StevenSVP, Research, DevelopmentS - Sale+OE$77.63-21,317144,255-13%-$1,654,8880-1-1
2017-03-13
DXCMValdes Jorge ACTOS - Sale$77.74-14,40044,521-24%-$1,119,5140+30
2017-03-10
DXCMBalo Andrew KEVP, Clinical, RegulatoryS - Sale$77.71-3,200116,033-3%-$248,6720+30
D
2017-03-09
DXCMLister JohnGM, EMEAS - Sale+OE$77.67-3,00084,034-3%-$233,002-1-1+1
D
2017-03-06
DXCMSkyler Jay SDirS - Sale+OE$78.13-31,89032,257-50%-$2,491,572-1-1+2
2017-02-23
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$78.42-3,18296,315-3%-$249,530+1+3+5
2017-02-22
DXCMRoper JessSVP, CFOS - Sale$78.76-2,33366,428-3%-$183,759+1+3+5
D
2017-02-17
DXCMSayer Kevin RPres, CEOS - Sale+OE$81.62-10,000299,391-3%-$816,177-1-1-2
D
2017-02-10
DXCMBalo Andrew KEVP, Clinical, RegulatoryS - Sale+OE$79.30-3,200103,872-3%-$253,760+3-1-5
D
2017-02-09
DXCMLister JohnGM, EMEAS - Sale+OE$79.73-3,00070,598-4%-$239,204+1+2-3
D
2017-02-09
DXCMValdes Jorge ACTOS - Sale+OE$79.76-7,00075,833-8%-$558,316+1+2-3
D
2017-02-01
DXCMValdes Jorge ACTOS - Sale+OE$80.00-13,90075,833-15%-$1,112,000-2-3-4
2017-01-23
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$79.50-3,18299,497-3%-$252,978-2-2-4
D
2017-01-23
DXCMPacelli Steven RobertEVP, Strategy, Corp. Dev.S - Sale+OE$79.99-9,637110,409-8%-$770,908-2-2-4
2017-01-18
DXCMRoper JessSVP, CFOS - Sale$85.01-3,01268,761-4%-$256,0510-1+2
D
2017-01-17
DXCMSayer Kevin RPres, CEOS - Sale+OE$85.94-10,000299,391-3%-$859,362-2-10
D
2017-01-13
DXCMLister JohnGM, EMEAS - Sale+OE$79.36-15,00070,598-18%-$1,190,400-3-5-1
D
2017-01-13
DXCMValdes Jorge ACTOS - Sale+OE$80.00-26,10075,833-26%-$2,088,000-3-5-1
D
2017-01-10
DXCMBalo Andrew KEVP, Clinical, RegulatoryS - Sale+OE$62.86-3,200106,345-3%-$201,152+26+20+18
D
2017-01-09
DXCMLister JohnGM, EMEAS - Sale+OE$63.02-3,00070,598-4%-$189,046-2+23+15
D
2017-01-09
DXCMValdes Jorge ACTOS - Sale+OE$63.02-10,90075,833-13%-$686,905-2+23+15
2016-12-23
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$62.17-3,182102,679-3%-$197,831-10+30
2016-12-14
DXCMRoper JessSVP, CFOS - Sale$64.14-2,44271,773-3%-$156,6190-2+33
D
2016-12-09
DXCMValdes Jorge ACTOS - Sale+OE$64.81-10,00075,833-12%-$648,079-1-2+4
2016-11-23
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$70.19-3,182105,861-3%-$223,350-4-9-11
2016-11-23
DXCMPacelli Steven RobertEVP, Strategy, Corp. Dev.S - Sale$70.32-10,300110,409-9%-$724,260-4-9-11
2016-11-09
DXCMLister JohnGM, EMEAS - Sale$62.50-3,41770,598-5%-$213,563+4+4-6
2016-10-24
DXCMRoper JessSVP, CFOS - Sale$80.75-2,47174,215-3%-$199,544-2+1-6+1
2016-10-24
DXCMPacelli Steven RobertEVP, Strategy, Corp. Dev.S - Sale$81.95-10,300120,709-8%-$844,065-2+1-6+1
2016-10-24
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$81.12-3,182109,043-3%-$258,110-2+1-6+1
2016-10-19
DXCMBalo Andrew KEVP, Clinical, RegulatoryS - Sale$82.31-4,997106,345-4%-$411,303-2-6-13-9
2016-10-14
DXCMSayer Kevin RPres, CEOS - Sale$81.87-7,000299,891-2%-$573,101+1-2-16-10
2016-10-10
DXCMLister JohnGM, EMEAS - Sale$84.41-3,56074,015-5%-$300,5080+1-24-6
D
2016-10-10
DXCMValdes Jorge ACTOS - Sale+OE$84.42-11,00075,833-13%-$928,5790+1-24-6
2016-10-05
DXCMBalo Andrew KEVP, Clinical, RegulatoryS - Sale$82.55-5,000111,342-4%-$412,750+1-1-25-5
2016-09-23
DXCMPacelli Steven RobertEVP, Strategy, Corp. Dev.S - Sale$94.00-10,300131,009-7%-$968,196-4-9-14-10
2016-09-23
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$93.97-3,182112,225-3%-$299,000-4-9-14-10
2016-09-22
DXCMRoper JessSVP, CFOS - Sale$93.99-2,47076,686-3%-$232,155-1-6-14-12
2016-09-21
DXCMBalo Andrew KEVP, Clinical, RegulatoryS - Sale$92.87-5,000116,342-4%-$464,3660-5-12-19
2016-09-14
DXCMSayer Kevin RPres, CEOS - Sale$91.79-7,000306,891-2%-$642,5270+1-12-15
2016-09-12
DXCMSkyler Jay SDirS - Sale$93.00-10,00032,257-24%-$930,000+1+1-11-16
M
2014-05-08
DXCMKahn BarbaraDirS - Sale$55.23-12,50029,095-30%-$690,366+1+1-11-16
2016-09-09
DXCMSkyler Jay SDirS - Sale$94.07-25,00042,257-37%-$2,351,7880+1-11-15
2016-09-09
DXCMLister JohnGM, EMEAS - Sale$93.65-3,56077,575-4%-$333,3920+1-11-15
2016-09-09
DXCMLister JohnGM, EMEAS - Sale$93.65-3,56077,575-4%-$333,3920+1-11-15
DM
2016-09-09
DXCMValdes Jorge ACTOS - Sale+OE$93.07-19,07175,833-20%-$1,774,8740+1-11-15
2016-09-07
DXCMFoletta Mark GDirS - Sale$94.62-1,80015,643-10%-$170,32500-10-15
D
2016-09-07
DXCMBalo Andrew KEVP, Clinical, RegulatoryS - Sale+OE$94.45-4,999130,010-4%-$472,15600-10-15
M
2016-09-07
DXCMGregg Terrance HExec COBS - Sale$95.29-10,740528,829-2%-$1,023,40000-10-15
2016-09-01
DXCMLord Jonathan T MdDirS - Sale$91.50-10,00052,820-16%-$915,000+1-1-13-17
2016-08-30
DXCMGregg Terrance HExec COBS - Sale$92.14-10,000539,569-2%-$921,3560+4-4-12
2016-08-24
DXCMGregg Terrance HExec COBS - Sale$92.72-10,000549,569-2%-$927,1510+1+2-13
D
2016-08-24
DXCMBalo Andrew KEVP, Clinical, RegulatoryS - Sale+OE$91.72-5,000129,979-4%-$458,6000+1+2-13
2016-08-23
DXCMDoubleday RichardEVP, Chief Commercial OfficerS - Sale$90.89-3,182124,075-3%-$289,224+1+1+4-13
2016-08-23
DXCMPacelli Steven RobertEVP, Strategy, Corp. Dev.S - Sale$90.74-10,300151,622-6%-$934,588+1+1+4-13
M
2016-08-22
DXCMGregg Terrance HExec COBS - Sale$90.81-20,000559,569-3%-$1,816,2230+2+4-13
2016-08-19
DXCMAltman Steven RDirS - Sale$90.91-3,50023,502-13%-$318,177-20+2-15
2016-08-19
DXCMSkyler Jay SDirS - Sale$90.77-25,00067,257-27%-$2,269,233+2+1+2-12
M
2016-08-18
DXCMGregg Terrance HExec COBS - Sale$90.70-40,000579,569-6%-$3,627,842+2+1+2-12
2016-08-15
DXCMSayer Kevin RPres, CEOS - Sale$90.78-7,000335,227-2%-$635,473+1+2+3-8
2016-08-15
DXCMGregg Terrance HExec COBS - Sale$91.01-14,942619,569-2%-$1,359,858+1+2+3-8
M
2016-08-11
DXCMLord Jonathan T MdDirS - Sale$90.64-10,000126,373-7%-$906,39900+1-12
2016-08-11
DXCMGregg Terrance HExec COBS - Sale$91.03-10,900634,511-2%-$992,28000+1-12
D
2016-08-10
DXCMBalo Andrew KEVP, Clinical, RegulatoryS - Sale+OE$90.26-5,000129,979-4%-$451,30000+3-12
2016-08-09
DXCMGregg Terrance HExec COBS - Sale$91.10-37,168645,411-5%-$3,385,9110-1+2-13
2016-08-09
DXCMLister JohnGM, EMEAS - Sale$91.07-3,56090,774-4%-$324,2170-1+2-13
D
2016-08-09
DXCMValdes Jorge ACTOS - Sale+OE$91.06-32,00093,217-26%-$2,913,9780-1+2-13
D
2016-08-09
DXCMSayer Kevin RPres, CEOS - Sale+OE$90.98-20,000342,227-6%-$1,819,5520-1+2-13
2016-08-08
DXCMKahn BarbaraDirS - Sale$90.52-6,00041,595-13%-$543,131+10+6-12
D
2016-08-05
DXCMValdes Jorge ACTOS - Sale+OE$91.22-25,00093,217-21%-$2,280,375-10+4-12
M
2016-05-11
DXCMGregg Terrance HExec COBS - Sale$79.81-35,000686,916-5%-$2,793,370-10+4-12
M
2016-07-29
DXCMMoy JeffreySVP, OperationsS - Sale$92.33-15,000120,181-11%-$1,385,000-2-2-1-15
D
2016-07-27
DXCMBalo Andrew KEVP, Clinical, RegulatoryS - Sale+OE$88.14-5,000129,979-4%-$440,700+3+1+1-11

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top